Baidu
map

硅胶隆乳安全吗?b超筛查硅胶乳房植入物是否存在无声破裂方便又便宜

2022-01-02 MedSci原创 MedSci原创

美国食品和药物管理局建议通过磁共振成像扫描来筛查硅胶乳房植入物是否存在无声破裂,但患者的依从性一直很低。高分辨率超声扫描是一种方便的替代方法,可提高筛查依从性;然而,女性对无声破裂的态度和感受以及她们

美国食品和药物管理局建议通过磁共振成像扫描来筛查硅胶乳房植入物是否存在无声破裂,但患者的依从性一直很低。高分辨率超声扫描是一种方便的替代方法,可提高筛查依从性;然而,女性对无声破裂的态度和感受以及她们对破裂筛查的渴望尚不清楚。

图1 文章来源

因此9家私人诊所的整形外科医生和工作人员接受了为期1天的高分辨率超声扫描培训,然后从2000年开始对植入硅胶的女性进行筛查。可疑的扫描结果由一位经验丰富的高分辨率超声整形外科医生进行复查,以确定是否显示出异常。手术和扫描结果相互关联。为了了解女性对无声破裂的态度和感受,她们在扫描前后进行了调查。

结果显示,在584名接受筛查的女性中,82名(14.0%)的扫描结果显示有异常;在1153个植入物中,92个(8.0%)显示破裂。40名扫描显示有破裂的妇女接受了手术,其中30名(75%)的破裂得到了确认。调查发现,99.5%的女性想知道自己是否有破裂,95.2%的女性想移除破裂的植入物。如果扫描显示没有破裂,女性会感到轻松,95.5%的女性会接受未来的高分辨率超声筛查,以确定是否有无声破裂。如果发现断裂,女性会表达各种担忧,87.8%的人会在12个月内取出断裂的植入物。

调查显示,使用硅胶假体的女性对可能的无声破裂感到担忧和焦虑。基于14%的女性在高分辨率超声扫描中显示植入物破裂,75%的女性在手术确认的高分辨率超声扫描中显示植入物破裂,本研究中10.6%的女性有无声破裂。

这项研究发现,硅胶植入物植入3至20年的女性中,无声破裂的患病率相对较高,患病率与植入时间的长短直接相关。

 

原始文章:

Salzman Marc J,Silent Rupture of Silicone Gel Breast Implants: High-Resolution Ultrasound Scans and Surveys of 584 Women.[J] .Plast Reconstr Surg, 2022, 149: 7-14.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1797710, encodeId=c7941e9771045, content=<a href='/topic/show?id=8d1423633a6' target=_blank style='color:#2F92EE;'>#乳房植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23633, encryptionId=8d1423633a6, topicName=乳房植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Dec 14 19:43:19 CST 2022, time=2022-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490947, encodeId=a6c3149094e5b, content=<a href='/topic/show?id=fb916268636' target=_blank style='color:#2F92EE;'>#植入物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62686, encryptionId=fb916268636, topicName=植入物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628846382, createdName=linagood, createdTime=Tue Jan 04 09:43:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520786, encodeId=36981520e865e, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Tue Jan 04 09:43:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618684, encodeId=26281618684e2, content=<a href='/topic/show?id=232f3859c9' target=_blank style='color:#2F92EE;'>#B超#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3859, encryptionId=232f3859c9, topicName=B超)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c57019929498, createdName=ms7524819409032184, createdTime=Tue Jan 04 09:43:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179933, encodeId=dde311e9933b0, content=别嘌呤醇是一种著名的黄嘌呤氧化酶抑制剂, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Mon Jan 03 08:32:41 CST 2022, time=2022-01-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1797710, encodeId=c7941e9771045, content=<a href='/topic/show?id=8d1423633a6' target=_blank style='color:#2F92EE;'>#乳房植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23633, encryptionId=8d1423633a6, topicName=乳房植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Dec 14 19:43:19 CST 2022, time=2022-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490947, encodeId=a6c3149094e5b, content=<a href='/topic/show?id=fb916268636' target=_blank style='color:#2F92EE;'>#植入物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62686, encryptionId=fb916268636, topicName=植入物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628846382, createdName=linagood, createdTime=Tue Jan 04 09:43:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520786, encodeId=36981520e865e, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Tue Jan 04 09:43:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618684, encodeId=26281618684e2, content=<a href='/topic/show?id=232f3859c9' target=_blank style='color:#2F92EE;'>#B超#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3859, encryptionId=232f3859c9, topicName=B超)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c57019929498, createdName=ms7524819409032184, createdTime=Tue Jan 04 09:43:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179933, encodeId=dde311e9933b0, content=别嘌呤醇是一种著名的黄嘌呤氧化酶抑制剂, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Mon Jan 03 08:32:41 CST 2022, time=2022-01-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1797710, encodeId=c7941e9771045, content=<a href='/topic/show?id=8d1423633a6' target=_blank style='color:#2F92EE;'>#乳房植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23633, encryptionId=8d1423633a6, topicName=乳房植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Dec 14 19:43:19 CST 2022, time=2022-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490947, encodeId=a6c3149094e5b, content=<a href='/topic/show?id=fb916268636' target=_blank style='color:#2F92EE;'>#植入物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62686, encryptionId=fb916268636, topicName=植入物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628846382, createdName=linagood, createdTime=Tue Jan 04 09:43:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520786, encodeId=36981520e865e, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Tue Jan 04 09:43:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618684, encodeId=26281618684e2, content=<a href='/topic/show?id=232f3859c9' target=_blank style='color:#2F92EE;'>#B超#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3859, encryptionId=232f3859c9, topicName=B超)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c57019929498, createdName=ms7524819409032184, createdTime=Tue Jan 04 09:43:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179933, encodeId=dde311e9933b0, content=别嘌呤醇是一种著名的黄嘌呤氧化酶抑制剂, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Mon Jan 03 08:32:41 CST 2022, time=2022-01-03, status=1, ipAttribution=)]
    2022-01-04 jiyangfei
  4. [GetPortalCommentsPageByObjectIdResponse(id=1797710, encodeId=c7941e9771045, content=<a href='/topic/show?id=8d1423633a6' target=_blank style='color:#2F92EE;'>#乳房植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23633, encryptionId=8d1423633a6, topicName=乳房植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Dec 14 19:43:19 CST 2022, time=2022-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490947, encodeId=a6c3149094e5b, content=<a href='/topic/show?id=fb916268636' target=_blank style='color:#2F92EE;'>#植入物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62686, encryptionId=fb916268636, topicName=植入物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628846382, createdName=linagood, createdTime=Tue Jan 04 09:43:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520786, encodeId=36981520e865e, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Tue Jan 04 09:43:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618684, encodeId=26281618684e2, content=<a href='/topic/show?id=232f3859c9' target=_blank style='color:#2F92EE;'>#B超#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3859, encryptionId=232f3859c9, topicName=B超)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c57019929498, createdName=ms7524819409032184, createdTime=Tue Jan 04 09:43:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179933, encodeId=dde311e9933b0, content=别嘌呤醇是一种著名的黄嘌呤氧化酶抑制剂, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Mon Jan 03 08:32:41 CST 2022, time=2022-01-03, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1797710, encodeId=c7941e9771045, content=<a href='/topic/show?id=8d1423633a6' target=_blank style='color:#2F92EE;'>#乳房植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23633, encryptionId=8d1423633a6, topicName=乳房植入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Dec 14 19:43:19 CST 2022, time=2022-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1490947, encodeId=a6c3149094e5b, content=<a href='/topic/show?id=fb916268636' target=_blank style='color:#2F92EE;'>#植入物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62686, encryptionId=fb916268636, topicName=植入物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=38628846382, createdName=linagood, createdTime=Tue Jan 04 09:43:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1520786, encodeId=36981520e865e, content=<a href='/topic/show?id=7a736264553' target=_blank style='color:#2F92EE;'>#植入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62645, encryptionId=7a736264553, topicName=植入)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=832411313664, createdName=jiyangfei, createdTime=Tue Jan 04 09:43:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1618684, encodeId=26281618684e2, content=<a href='/topic/show?id=232f3859c9' target=_blank style='color:#2F92EE;'>#B超#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3859, encryptionId=232f3859c9, topicName=B超)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c57019929498, createdName=ms7524819409032184, createdTime=Tue Jan 04 09:43:19 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179933, encodeId=dde311e9933b0, content=别嘌呤醇是一种著名的黄嘌呤氧化酶抑制剂, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIrrxxDxnLic8t6EAs38Qfwo6H2h6JMleIgb9OSYf6LMnVDkQEqUXWoSDWboibjhOBI9SJDTXweqQIA/132, createdBy=50aa5321359, createdName=查查佳佳, createdTime=Mon Jan 03 08:32:41 CST 2022, time=2022-01-03, status=1, ipAttribution=)]
    2022-01-03 查查佳佳

    别嘌呤醇是一种著名的黄嘌呤氧化酶抑制剂

    0

相关资讯

女子隆胸猝死手术台,两次死因鉴定结果不同

32岁的董女士在大连艺星医疗美容医院进行隆胸手术时,在手术台上呼吸、心跳骤停,抢救无效去世。北京青年报记者从死者家属处获悉,大连市卫健委委托司法鉴定机构对董女士的死亡原因进行了两次鉴定,第一次鉴定认为当事人符合因双肺脂肪栓塞伴过敏反应,继发DIC(弥散性血管内凝血)而死亡;在2019年12月20日的第二次鉴定结论中,认为董女士的死亡符合在手术过程中使用的麻醉药物作用所致。32岁女子隆胸呼吸骤停20

患者满意度研究结果来了!胸下乳房重建和胸前乳房重建哪种术式会让患者术后幸福感更高?

近年来,胸下乳房植入物在乳房重建中占主导地位,但最近更多地采用胸前乳房植入物重建。迄今为止,比较两种技术的患者报告结果的研究有限。

PRS:当前对乳房植入物的安全性和实用性的看法

改进的方框标签可以提高非专业女性对乳房植入物安全性及效用的看法,并影响决策。然而,对乳房植入物的更严格的审查不应该阻止需要隆胸的女性接受隆胸。 鉴于乳房植入物在乳房重建和隆胸中发挥着重要作用,医生们应

BMJ:隆胸需谨慎!乳房植入物被证实与罕见癌症有关

7月24日,制药公司Allergan宣布,受美国食品药品监督管理局(FDA)要求在全球范围内召回其Biocell纹理乳房植入物。其召回原因在于:这种乳房假体可能与一种被称为间变性大细胞淋巴瘤(BIA-ALCL)的罕见癌症有关。

PFS:10年随访结果出炉!记忆凝胶植入物用于隆胸或乳房再造安全有效

记忆凝胶乳房植入物于2006年11月获得美国食品和药物管理局(FDA)的批准,用于22岁及以上女性的隆胸和任何年龄女性的乳房再造。10年随访结果表明,记忆凝胶植入物用于隆胸或乳房再造是安全和有效的。

重要速看!大数据告诉你哪些因素容易引起隆胸术后早期并发症!

早期并发症发生在手术后数周内,包括血肿、早期血清肿、感染、植入物丢失和伤口破裂。

拓展阅读

ASJ:Mentor MemoryGel Xtra乳房假体的临床结果

该研究首次发表了Mentor MemoryGel Xtra乳房假体的前瞻性临床数据,其3年随访数据支持MemoryGel Xtra乳房假体的安全性和有效性。

PRS:羧甲基甲壳素对硅胶种植体周围胶囊的影响

包膜挛缩是隆乳术后发生的严重并发症。羧甲基甲壳素具有以下四个特性:抑菌作用、抑制成纤维细胞生长、止血作用和屏障功能,在临床广泛用作抗粘连剂。

经腋窝切口入路内窥镜辅助下行假体隆乳术

经腋窝切口入路行假体隆乳是我国隆乳术的重要手术方式之一。随着微创外科理念的进步和外科手术器械的发展,经腋窝切口入路(以下简称“经腋路”)在内窥镜辅助下剥离乳腺后或胸大肌后腔隙完成假体置入,逐渐成功 运用于美容外科临床,取得了较好的临床效果[1-7]。然而部分医院和医生对内窥镜辅助隆乳的临床优势认识不足,一些就医者因费用问题对内窥镜辅助隆乳接受度不高。本文以本院2014年1月-2017年5月收治的经

Baidu
map
Baidu
map
Baidu
map